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Abstract: Plant defensins are small, cysteine-rich peptides that possess biological activity 
towards a broad range of organisms. Their activity is primarily directed against fungi, but 
bactericidal and insecticidal actions have also been reported. The mode of action of various 
antifungal plant defensins has been studied extensively during the last decades and several 
of their fungal targets have been identified to date. This review summarizes the mechanism 
of action of well-characterized antifungal plant defensins, including RsAFP2, MsDef1, 
MtDef4, NaD1 and Psd1, and points out the variety by which antifungal plant defensins 
affect microbial cell viability. Furthermore, this review summarizes production routes for 
plant defensins, either via heterologous expression or chemical synthesis. As plant defensins 
are generally considered non-toxic for plant and mammalian cells, they are regarded as 
attractive candidates for further development into novel antimicrobial agents. 
Keywords: mechanism of action; antimicrobial peptide; plant defensin; RsAFP2; NaD1; 
MsDef1; MtDef4; Psd1; heterologous protein expression; chemical protein synthesis 
 
1. Introduction 
Like all living organisms, plants are repeatedly confronted with attacks by for instance insects, 
fungi and bacteria. In order to cope with these pests and pathogens, plants have developed a number of 
defence mechanisms, including the production of antimicrobial peptides (AMPs). Expression of these 
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AMPs can be constitutive in e.g., storage organs and reproductive tissues or can be induced 
systemically as well as locally, in e.g., leaves, during microbial invasion or injury [1–3]. Plant AMPs 
are small cationic peptides that exert biological activity against a broad range of organisms. Their 
activity is primarily directed against fungi, but bactericidal and insecticidal actions are also reported. 
These defence-related peptides have a compact structure that is stabilized by intramolecular disulphide 
bridges, enhancing structural and thermodynamic stability [2]. Based on their tertiary structure, they 
are subdivided into distinct classes, being thionins, defensins, knottins, lipid transfer proteins, heveins, 
snakins and cyclotides (reviewed in [2,4–7]). As the scope of this review is focused on plant defensins, 
the other classes of AMPs will not be discussed. For more detailed information on antifungal AMPs, 
the reader is referred to [8–10]. 
2. Plant Defensins 
Plant defensins are present in all plant families, including the Brassicaceae, Fabaceae and 
Solanaceae. These peptides were primarily found in the seeds, but leaves and flowers are also common 
sources [11–16]. They are either constitutively expressed in storage and reproductive organs or 
produced upon pathogenic attack or injury as part of a systemic defence response [2]. In addition, 
production of plant defensins is also induced in response to environmental stress, such as  
drought [17,18], and signalling molecules, including methyl jasmonate, ethylene and salicylic acid [19,20]. 
2.1. Structure 
Plant defensins are small, cationic peptides with a length of approximately 45–54 amino acids. 
Their structure typically comprises a cysteine-stabilized αβ-motif (CSαβ) with a prominent α-helix and 
a triple-stranded antiparallel β-sheet that is stabilized by four disulphide bridges [21–23]. A subclass  
of the plant defensin family comprises defensins with 10 cysteine residues, resulting in a total  
of five disulphide bonds. The fifth disulphide bond seems to reinforce a conserved hydrogen bond and 
is likely to confer additional thermodynamic stability of the defensin, as compared to other defensins, 
by replacing non-covalent hydrophobic interactions or hydrogen bonds with a covalent bond [24].  
To our knowledge, this extra pair of cysteines has only been reported for PhD1 and PhD2, both floral 
defensins isolated from Petunia hybrida [16,24]. 
According to the structure of their precursor protein, plant defensins can be subdivided into two 
groups. A first group comprises defensins in which the precursor is composed of a signal sequence and 
a mature defensin domain. The signal sequence targets the protein to the endoplasmic reticulum, where 
it is folded and subsequently enters the secretory pathway. In a second and less common group, the 
precursor protein contains an additional C-terminal prodomain that is proteolytically removed during 
or after transit through the secretory pathway [16,25]. This type of defensins have been identified in 
solanaceous plants, such as Nicotiana alata and Petunia hybrida [16]. Recently, Lay and co-workers 
assigned a cytoprotective and subcellular targeting function to this prodomain [26]. 
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2.2. Biological Activity 
Plant defensins possess a variety of biological activities (reviewed in [27–29]). They have been 
reported to inhibit protein synthesis, enzyme activity and ion channel function. Some plant defensins 
even exhibit antiproliferative activity towards cancer cells or proved effective against HIV reverse 
transcriptase. To date, only a few plant defensins are shown to inhibit the growth of bacteria, whereas 
their antifungal activity has been studied extensively [27,28]. It has become clear that, although a 
similar activity might be observed for several defensins, their mode of action can be extremely  
diverse with regard to target molecules and (sub)cellular localization [30]. In order to illustrate this 
variety, this review will focus on the mode of antifungal action of plant defensins isolated from 
Raphanus sativus (RsAFP2), Pisum sativum (Psd1), Medicago spp. (MsDef1 and MtDef4) and 
Nicotiana alata (NaD1). 
3. Mode of Action of Plant Defensins 
Extensive research during the past decades has allowed us to identify a number of key features by 
which plant defensins exert their antimicrobial activity. It has been demonstrated that defensins can 
specifically interact with host membrane compounds, such as bacterial lipid II receptors (reviewed  
in [31]), fungal sphingolipids (reviewed in [31]) and fungal phospholipids [32]. Fungal sphingolipids 
are classified into two groups, i.e., phosphosphingolipids and glycosphingolipids (GSLs). The most 
common GSL is glucosylceramide (GlcCer), which is synthesized by glucosylceramide synthase, 
encoded by the GCS gene, and glycoinositolphosphorylceramide (GIPC) [33,34]. The latter can be 
further subdivided into inositolphosphorylceramide (IPC), mannosyl-IPC (MIPC) and mannosyldi-IPC 
(M(IP)2C), which are formed by sequential addition of inositolphosphate and mannose. The final step 
in this reaction, i.e., converting MIPC to M(IP)2C, requires inositolphosphate transferase, encoded by 
the IPT1 gene (reviewed in [35]). Different plant defensins have been shown to interact with different 
classes of sphingolipids: the plant defensin RsAFP2 from radish [11] interacts with GlcCer [36], 
whereas the plant defensin DmAMP1 from dahlia [37] interacts with M(IP)2C [38,39]. In contrast, the 
plant defensins NaD1 from tobacco was recently shown to interact with a variety of phospholipids, 
including phosphatidylinositol mono-/bis-/tri-phosphates, phosphatidylserine and phospatidic acid, but 
not with sphingolipids [32]. In case of plant defensins that interact with sphingolipids, it was found 
that the presence of specific sphingolipids was essential mediating cell death of fungi and yeast, since 
yeast mutants deficient in genes involved in sphingolipid biosynthesis were resistant towards these 
peptides. For instance, S. cerevisiae strains with a non-functional IPT1 allele, and thus lacking 
M(IP)2C in their membranes, were found highly resistant towards DmAMP1 as compared to the wild 
type (WT) [38]. In line, deletion of the GSC gene resulted in an increased resistance towards RsAFP2 
for Pichia pastoris and Candida albicans knockout strains as compared to the corresponding  
WTs [36]. Similar observations were made for MsDef1 and a Δgcs Fusarium graminearum strain [40]. 
Furthermore, Neurospora crassa mutants displaying structurally different GlcCer, novel 
glycosphingolipids and an altered level of steryl glucosides in their membranes were found more 
resistant towards RsAFP2, DmAMP1 and HsAFP1 when compared to the WT, suggesting that the 
specific structure of sphingolipids in the fungal membrane is crucial for sensitivity towards plant 
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defensins [41]. In addition, interaction of Sd5 and Psd1 with respectively fungal GlcCer- [42] and 
phosphatidylcholine- (PC) [43] containing vesicles further highlights the importance of fungal 
sphingolipids as interaction sites for plant defensins. 
Upon interaction with their target, plant defensins are either internalized by the fungal cell and 
interact with intracellular targets, or they stay at the cell surface and induce cell death through 
induction of a signalling cascade. While the latter has been reported for RsAFP2 [44], cellular uptake 
was observed for NaD1 [45,46], MtDef4 [47] and Psd1 [48]. Recently, Sagaram and colleagues 
identified a RGFRRR motif in the MtDef4 sequence that is thought to be a translocation signal 
required for fungal cell entry, since replacement of this motif with AAAARR or RGFRAA abolished 
the ability of the peptide to enter the cell [47]. However, this sequence is, to our knowledge, not 
present in other plant defensins that enter the fungal cell. This suggests multiple mechanisms by which 
defensins are internalized by the cell. Proposed mechanisms include receptor-mediated internalization, 
membrane translocation (i.e., transient membrane permeabilization and lipid-assisted pore formation) 
and membrane permeabilization (reviewed in [49]). Membrane permeabilization has been described 
for plant defensins, however, it is suggested to be a secondary effect rather than the key to microbial 
killing, since it only occurs at concentrations well above the concentration required for growth 
inhibition [50]. Alternatively, ROS production and hence oxidative stress, most often play a role in 
defensin-mediated cell death, as has been reported for many plant defensins including RsAFP2 [51], 
HsAFP1 [52], DmAMP1 [53] and NaD1 [45]. 
Another common feature of plant defensins is the loss of their antifungal activity by an increase in 
ionic strength of the growth medium. Especially divalent cations, such as Ca2+ and Mg2+, seem to play 
an important role in this phenomenon [11,13,15,37,54]. Since the antagonistic effect strongly depends 
on the test fungus and type of the defensin, it is suggested that electrostatic interactions alter the target 
site on the fungal membrane, and hence reduce the affinity of the defensin to bind the membrane, 
rather than altering the conformation of the defensin itself [55]. However, Oard and Karki proposed 
another mechanism for inhibition of antimicrobial activity by cations which is in contrast with this 
interpretation. They found that the structure of β-purothionin, a thionin purified from wheat, is altered 
by the presence of K+ and Mg2+, making the peptide more rigid and impairing interaction with its 
target. Structural changes in this case include elongation of α1-helix, unfolding of α2-helix and an 
overall change in loop conformation [56]. Inhibition of antimicrobial activity by the presence of 
cations seems to be a common theme for AMPs in general, since it is also observed for thionins, insect 
defensins and mammalian defensins and is not solely associated with antifungal activity [56–60].  
In order to illustrate the variety of mechanisms of action by which plant defensins exhibit their 
antifungal activity, four case studies will be discussed in the next sections. The plant defensins 
discussed include RsAFP1 and RsAFP2 from radish [11], Psd1 from pea pods [13], MsDef1 from 
alfalfa [14] and MtDef4 from barrel clover [61], and NaD1 from tobacco [16] and are listed in Table 1. A 
multiple alignment of the amino acid sequences of these defensins is presented in Figure 1, in which 
the regions important for their antifungal activity are highlighted.  
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Table 1. Overview of the plant defensins discussed in this review. NA: not available. 
Defensin Name Source UNIPROT Accession Number 
Protein Data Bank 
Accession Number Reference 
RsAFP1 Radish seeds P69241 1AYJ [11] 
RsAFP2 Radish seeds P30230 NA [11] 
MsDef1 Alfalfa seeds Q9FPM3 1H3R (theoretical model) [14] 
MtDef4 Barrel clover seeds G7L736 2LR3 [61] 
Psd1 Pea pods P81929 1JKZ [13] 
NaD1 Tobacco flowers Q8GTM0 1MR4 [62] 
Figure 1. Amino acid sequence alignment of RsAFP1, RsAFP2, MsDef1, MtDef4, Psd1 
and NaD1. Multiple alignment was performed using the alignment tool from UniProt. 
Cysteine-pairing is shown at the top of the figure. Highly conserved residues are shown in 
grey; (-) denote gaps in the alignment. Arrows represent the position of the β-strands; the 
helix represents the position of the α-helix. Purple boxes indicate regions important for 
antifungal activity: boxes with dashed and full lines in the RsAFP1 sequence represent the 
first and second site in the tertiary structure, resp., important for antifungal activity [15,47,63]; 
blue boxes represent peptide fragments that exhibit antifungal activity similar to the 
parental peptide and hence, are important for antifungal activity [43,47,63,64]. 
 
A schematic overview of the proposed mechanism of action of the plant defensins discussed in this 
review is given in Figure 2. 
3.1. Plant Defensins from Radish: RsAFP1 and RsAFP2 
RsAFP1 and RsAFP2 are antifungal defensins found in the seeds of radish [11,36,65]. Regarding 
their antifungal activity, it was shown that RsAFP2 is more potent than RsAFP1 (2-30-fold dependent 
on the test fungus), although differences between the two peptides solely consist of two amino acid 
substitutions [11]. Analysis of the RsAFP2 primary structure showed two adjacent sites involved in 
antifungal action. 
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Figure 2. Schematic overview of the proposed mechanisms of action of the plant defensins discussed in this review. (A) RsAFP1 and 
RsAFP2; (B) Psd1; (C) MsDef1; (D) MtDef4; (E) NaD1. For detailed information on the Roman numerals displayed in the figures, the reader 
is referred to Section 3.1 (A), 3.2 (B), 3.3 (C), 3.4 (D) and 3.5 (E) of this review. 
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These two regions might constitute two sites contacting a single receptor/interaction site or might 
indicate two binding sites that interact with two receptor/interaction sites [66]. The membrane target of 
RsAFP2 has been identified as fungal GlcCer [36] and since sphingolipids, such as GlcCers, are 
clustered with other membrane compounds to form lipid rafts [67], the hypothesis of RsAFP2-interaction 
with multiple interaction sites is plausible. 
Interaction of RsAFP2 with its membrane target is essential, however not sufficient for antifungal 
activity, as [Y38G]RsAFP2, an RsAFP2 variant devoid of antifungal activity, is able to interact with 
GlcCer [36,66]. Other RsAFP2-associated aspects leading to fungal cell death have been described. 
Ion fluxes take part in RsAFP2-induced cell death, since a rapid K+ efflux and Ca2+ influx was 
observed in RsAFP2-treated N. crassa hyphae [50]. Moreover, Ca2+ influx has been correlated with the 
antifungal potency of RsAFP2 [66], however, no blockage of L-type Ca2+ channels is observed [15]. In 
addition, production of ROS was shown in RsAFP2-treated C. albicans cells, suggesting a downstream 
signalling cascade of RsAFP2-binding to GlcCer [51]. In line with these findings, Aerts and colleagues 
demonstrated that RsAFP2 induces programmed cell death or apoptosis in C. albicans. Moreover, 
RsAFP2-induced apoptosis involves caspases, but not metacaspase Mca1 [68]. 
Cell wall stress has been associated with RsAFP2 activity as well. As GlcCers are also abundant in 
the cell wall (i.e., approx. 40% of GlcCer is located in the cell wall) [44], this is not surprising. 
RsAFP2 activates the cell wall integrity pathway by increasing the level of dually phosphorylated 
Mkc1p [44], a MAP kinase in C. albicans associated with oxidative stress, changes in osmotic 
pressure, cell wall damage and a decrease in growth temperature [69]. In line, RsAFP2 was shown to 
activate MAP kinase signalling cascades in F. graminearum, without involvement of the Hog1 MAP 
kinase pathway [61]. Furthermore, RsAFP2 was found to induce accumulation of membrane 
phytoC24-ceramides, affect septin formation and localization and impair the yeast-to-hyphae transition 
in C. albicans [44].  
The exact binding site of RsAFP2 to GlcCer is still unknown, however, the region encompassing 
the β2-β3 loop is suggested to play a role in binding to the fungal membrane, as synthetic derivatives 
of this region, displayed in Figure 1, exhibited antifungal activity and binding to the membrane is 
essential to induce fungal cell death [64,66,70]. Furthermore, position 38 and 39 were shown critical 
for antifungal action, as amino acid substitutions at these positions significantly altered the potency of 
the peptide in vitro [66]. Interestingly, [Y38G]RsAFP2, which is devoid of antifungal activity, is still 
able to interact with its membrane target, and hence, target binding and antifungal activity seem not 
controlled by the same peptide region [36]. Noteworthy is the fact that loop regions have been 
demonstrated to be important for antifungal activity in other plant defensins as well, including Psd1, 
MsDef1 and MtDef4 [15,43,63]. 
In conclusion, the mode of action of RsAFP2 is suggested to involve (i) recognition of and binding 
with GlcCer in the fungal membrane and cell wall; (ii) activation of the CWI pathway and MAP kinase 
signalling pathways, excluding the Hog1 MAP kinase pathway; (iii) production of ROS; (iv) induction 
of ion fluxes; (v) activation of caspases, but not metacaspase; (vi) induction of cell wall stress;  
(vii) accumulation of membrane phytoC24-ceramides; (viii) abnormal septin formation and localization; 
(ix) impairment of the yeast-to-hyphae transition and (x) fungal cell death. In which order step (ii) to 
(ix) take place, has yet to be elucidated. A schematic overview of the proposed mechanism of action of 
RsAFP2 can be found in Figure 2A. 
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3.2. Plant Defensin from Pea: Psd1 
Psd1 is an antifungal defensin isolated from pea seeds [13]. Almeida and colleagues estimated other 
biological activities of Psd1 based on in silico analysis of the surface topology using various  
well-characterized defensins and toxins. Although no correlation could be demonstrated between 
antifungal or antibacterial activity and the surface electrostatic potential of the considered peptides, the 
study showed a clear correlation between K+ channel inhibitory activity and peptide surface topology. 
Since Psd1 shows a surface topology similar to that of peptides and toxins belonging to the latter 
group, it is therefore implied to act as a K+ channel inhibitor [71].  
The fungal membrane target of Psd1 has not yet been identified, but is suggested to be GlcCer 
and/or ergosterol [43,72]. Analysis of the Psd1 lipid selectivity by fluorescence spectroscopy revealed 
that the peptide is likely to be adsorbed on or slightly inserted into the fungal membrane during initial 
interaction. Furthermore, this study showed that Psd1 does not interact with membranes containing 
GlcCer derived from soybean, nor with cholesterol-enriched lipid bilayers, such as mammalian cell 
membranes, which highlights its therapeutic potential [72]. The exact binding site for membrane 
interaction is thought to be Psd1 Loop1, displayed in Figure 1, since the peptide corresponding to this 
region still interacts with GlcCer-containing vesicles. Moreover, this region was found to exhibit 
significant conformational changes upon binding with GlcCer, as compared to the conformational 
accommodation during nonspecific binding to phosphocholine. Hence, interaction of Psd1 with the 
fungal membrane is probably due to conformational selection [43]. 
Upon membrane binding, Psd1 is internalized by the cell and interacts with nuclear proteins, as was 
shown via a GAL4-based yeast two-hybrid assay by Lobo and colleagues [48]. Cyclin F was identified 
as the main target of Psd1, which plays a key role in nuclear translocation of Cyclin B and cell cycle 
progression [48,73–75]. In vivo studies with Psd1 on retinal neuroblasts showed that Psd1 affects 
interkinetic nuclear migration and hence, impairs cell cycle progression [48].  
Taken together, the mechanism of action of Psd1 is not yet completely understood, however, a 
proposed mode of action includes (i) adsorption on the fungal membrane surface; (ii) interaction with 
GlcCer and/or ergosterol in the fungal membrane; (iii) insertion of Psd1 into the fungal membrane;  
(iv) nuclear translocation and interaction with Cyclin F, resulting in cell cycle impairment and  
(v) fungal cell death. In which order step (iii) to (v) take place has yet to be identified. A schematic 
overview of the proposed mechanism of action of Psd1 is represented in Figure 2B. 
3.3. Plant Defensins from Medicago spp.: MsDef1 and MtDef4 
MsDef1 and MtDef4 are antifungal defensins found in Medicago spp. [14,61]. MsDef1 is suggested 
to display a similar mode of antifungal action as the virally encoded toxin KP4 from the fungus 
Ustilago maydis, since both peptides strongly block the mammalian L-type Ca2+ channel in a specific 
manner [15]. Interaction of toxins with K+ channels has been reported by Zhu and colleagues, who 
hypothesized that defensins with a Lys-Cys4-Xaa-Asn motif interact with K+ channels when the 
flexible loop of the peptide is deleted and hence, steric hindrance is reduced [76]. The same might hold 
true for other ion channels, such as Ca2+ channels. Similarities in modes of action between KP4 and 
MsDef1 are further demonstrated by a more pronounced hyperbranching of fungal hyphae upon 
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treatment with these peptides as compared to treatment with RsAFP2 [15]. Moreover, the antifungal 
activity of MsDef1 and KP4 is strongly abrogated by addition of exogenous Ca2+ and since addition of 
other metals (K+, Mg2+ and Na+) did not affect peptide activity, Ca2+ is suggested to be involved in 
MsDef1 mode of action [15]. Recently, Muñoz and colleagues confirmed that MsDef1, as well as 
MtDef4, disrupt Ca2+ signalling and/or homeostasis and that this phenomenon is not caused by direct 
membrane permeabilization [77]. 
GCS was found essential in MsDef1-mediated growth inhibition, which implies the involvement of 
GlcCer as a fungal membrane target [40]. This is in line with recent findings by Muñoz and colleagues 
who concluded that MsDef1-sensitivity is mediated by GlcCer in filamentous fungi [77]. Molecular 
targets involved in MsDef1-tolerance include MAP kinase signalling cascades, with exception of the 
Hog1 MAP kinase pathway, and were similar to the observations made for RsAFP2. Immunoblot 
analysis revealed rapid activation of Gpmk1 and Mgv1 MAP kinases upon MsDef1 treatment [61], 
which regulate processes related to cell wall integrity, sexual reproduction and pathogenicity [78,79]. 
Interestingly, RsAFP2 activates the cell wall integrity pathway and exerts its antifungal activity from 
the extracellular space [44]. Since MsDef1 and RsAFP2 seem to activate the same MAP kinase 
signalling cascades [61], they are suggested to have a similar mode of action. Hence, MsDef1 is 
suggested to induce fungal cell death through activation of signalling cascades involving MAP kinases 
without entering the fungal cell. 
In contrast to MsDef1 activity, GCS is not important for MtDef4-mediated fungal growth inhibition 
and MtDef4 activity seems independent of MAP kinase signalling cascades. Furthermore, MsDef1 
induces extensive hyperbranching of fungal hyphae, whereas MtDef4 does not, suggesting different 
mechanisms of action for MsDef1 and MtDef4 [61]. Both peptides were shown to induce membrane 
permeabilization, however, membrane permeabilization was significantly higher in hyphae treated 
with MtDef4 as compared to treatment with MsDef1, which is consistent with the in vitro antifungal 
potency of the peptides [63]. Sagaram and colleagues reported internalization of MtDef4 in the fungal 
cell and identified the RGFRRR motif in the MtDef4 sequence as a translocation signal that is required 
for fungal cell entry. In addition, MtDef4 was shown to interact with cytosolic phosphatidic acid (PA), 
dependent on the presence of the RGFRRR motif [47]. These results are consistent with previous 
findings that correlate the antifungal activity of MtDef4 with the presence of that motif [63]. Recently, 
Muñoz and colleagues reported that MsDef1 and MtDef4 affect conidial germination, conidial 
anastomosis tube fusion and conidial cell death in N. crassa in significantly different ways. High 
fungicidal concentrations of MtDef4 caused rapid and complete inhibition of germination, with cell 
death occurring rather fast, whereas treatment of conidia with high MsDef1 concentrations resulted in 
a delayed cell death and complete inhibition of germination was not reached. Moreover, it was shown 
that the RGFRRR motif in MtDef4 is not only important for cell entry and binding to PA, but it 
furthermore plays a role in inhibition of cell fusion [77]. 
As is the case for various plant defensins, structure-activity studies have been performed for 
MsDef1 and MtDef4. Both the N-terminal and the C-terminal region of MsDef1, displayed in Figure 1, 
were found important for antifungal activity and, in line with the observations made for RsAFP2, 
position 38 is critical for antifungal action [15,66]. The MsDef1 and MtDef4 C-terminal domains are 
also suggested to play a role in Ca2+ homeostasis [77]. Furthermore, Spelbrink and colleagues 
demonstrated the importance of the loops for antifungal activity in the MsDef1 tertiary structure, 
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which has been reported for Psd1, RsAFP2 and MtDef4 as well [15,43,63,66,70]. Structure-activity 
determinants of MtDef4 demonstrated the importance of the γ-core motif, composed of β2 and β3 
strands and the interposed loop, for antifungal activity. Here, cationic and hydrophobic residues are 
considered important for antifungal action, as the MtDef4 γ-core alone is able to inhibit fungal growth, 
whereas the γ-core of MsDef1 is not. Both F37 and R38 are critical for antifungal activity in MtDef4, 
since the hexapeptide RGFRRR present in the MtDef4 γ-core is capable of inducing growth inhibition 
and membrane permeabilization, while RGARRR and RGFARR are not [63]. In addition, replacement 
of RGFRRR with RGFRAA or AAAARR abolished the ability of the peptide to enter the fungal cell 
as well as to interact with intracellular PA, suggesting that both fungal cell entry and PA binding  
are mediated by the RGFRRR loop [47], again highlighting the importance of peptide loops for 
antifungal activity. 
In conclusion, MsDef1 and MtDef4 seem to have different mechanisms of antifungal action, 
however, their complete mode of action remains to be elucidated. The proposed mechanism of 
antifungal action for MsDef1 includes: (i) interaction with the fungal membrane, presumably GlcCer; 
(ii) activation of Gpmk1 and Mgv1 MAP kinase signalling cascades; (iii) (partial) inhibition of 
conidial germination; (iv) disruption of Ca2+ signalling and/or homeostasis and (v) delayed fungal cell 
death. In which order step (ii) to (v) take place has yet to be identified. The hypothesized mechanism 
of action of MtDef4 comprises (i) recognition of the fungal membrane; (ii) translocation of the peptide 
to the cytosol via the RGFRRR motif; (iii) interaction with cytosolic PA and supposedly subsequent 
interference with PA signalling and/or biosynthesis; (iv) disruption of Ca2+ signalling and/or 
homeostasis; (v) inhibition of conidial germination; (vi) inhibition of cell fusion and (vii) rapid fungal 
cell death. In which order (ii) to (vii) take place remains to be elucidated. A schematic overview of the 
proposed mechanism of action of MsDef1 and MtDef4 is given in Figure 2C,D, respectively. 
3.4. Plant Defensin from Tobacco: NaD1 
NaD1 is a floral defensin from the tobacco plant and exhibits antifungal properties [16]. The 
membrane target of NaD1 was recently identified by Poon and colleagues as the phospholipid PIP2, 
which is present in eukaryotic cell membranes. It was shown that NaD1 forms 14-mer oligomers, 
mediated by PIP2, and that this oligomerization is important for membrane permeabilization and lysis 
of the fungal cell [32]. Upon interaction and permeabilization of the cell membrane, NaD1 enters 
fungal hyphae and is localized to the cytoplasm, where it causes granulation of the cytoplasm and 
induces ROS production [45]. NaD1 is implied to induce cell death via oxidative stress, as ROS and 
nitric oxide (NO) production was observed upon treatment of C. albicans cells [80]. These findings are 
consistent with results reported by Bleackley and colleagues, in which mitochondrial genes are 
implicated in NaD1 mode of action [81]. 
Recently, Hayes and colleagues reported the importance of the high-osmolarity glycerol (HOG) 
pathway in tolerance to NaD1, being the sole stress-responsive pathway involved in NaD1 action that 
was screened in this study [80]. Although the HOG pathway is mainly involved in protection against 
osmotic stress and osmotic stress does not contribute significantly to NaD1 mode of action [80], these 
findings are not surprising, since Hog1p is also known to participate in tolerance to oxidative  
stress [82]. Interestingly, the HOG pathway is excluded in the mode of action of MsDef1 and RsAFP2, 
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whereas other MAP kinase signalling cascades play a key role in tolerance to these defensins [61]. 
These findings clearly suggest distinct modes of action of MsDef1 and RsAFP2 on the one hand, and 
NaD1 on the other. Another novel finding in the NaD1 mechanism of action is the identification of 
Agp2p as a regulator of the potency of the peptide [81]. Agp2p is a plasma membrane protein that 
regulates the transport of positively charged molecules. Upon NaD1 treatment, cells lacking AGP2 
show a delayed membrane permeabilization, reduced uptake of NaD1 and are overall more resistant to 
NaD1 treatment compared to the WT. Deletion of AGP2 probably results in an accumulation of 
positive charges on the surface of the cell, thereby repelling cationic peptides from the surface [81].  
Taken together, the NaD1 mechanism of action includes (i) interaction with the fungal cell 
membrane; (ii) translocation to the cytoplasm; (iii) PIP2-mediated oligomerization of NaD1 (14-mer) 
(iv) membrane permeabilization; (v) possible interaction with intracellular targets; (vi) ROS and NO 
production, i.e., oxidative stress; (vii) activation of the HOG pathway; (viii) membrane disruption and 
(ix) fungal cell death. In which order (ii) to (ix) take place has yet to be identified. A schematic 
overview of the proposed mechanism of action of NaD1 is shown in Figure 2E. 
4. Production of Plant Defensins 
Due to their selective toxicity towards microbial cells and their unique mode of action, plant 
defensins are attractive candidates for further development as novel antimicrobial agents. However, 
development of plant defensins for medicinal or biotech purposes requires large amounts of purified 
peptides. Extraction of plant defensins from natural sources is rather complicated due to their low 
abundance and the presence of a variety of other compounds in these plant parts. Chemical synthesis 
and heterologous production are therefore convenient alternatives to obtain large amounts of functional 
peptides. In addition, these approaches allow for the production of mutant peptides, which are 
interesting to include in structure-activity studies. In the following part, these techniques as well as 
their advantages and drawbacks are discussed. 
4.1. Chemical Synthesis of Proteins 
Synthesis of proteins by chemical means has recently gained interest, as it allows the generation of 
proteins that cannot be produced biologically, e.g., labelled peptides. Various strategies have been 
developed in which proteins can be synthesized, often consisting of combinations of solid-phase 
peptide synthesis (SPPS), native chemical ligation (NCL) and enzyme-catalyzed ligation (reviewed  
in [83–86]).  
In SPPS, a peptide is synthesized in a stepwise manner on a polymeric resin through sequential 
steps of coupling and deprotection of protected amino acids. Both Fmoc (9-fluorenylmethyl carbamate) 
and Boc (di-tert-butyl dicarbonate) strategies can be used in SPPS to protect the N-terminus of the 
amino acid being coupled and hence prevent polymerization or non-specific reactions (reviewed  
in [87–89]. SPPS plays a key role in peptide synthesis, however, studies have shown that following 
this method, only peptides containing less than 50 amino acids can be reliably prepared with 
acceptable yields and purity [83]. Hence, other strategies have to be implemented when synthesizing 
larger peptides and proteins. To this end, a strategy of peptide segment condensation is used in which 
unprotected peptide fragments, often produced by SPPS, are subjected to ligation methods such as 
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NCL. Subsequent cycles of NCL results in the formation of a linear polypeptide chain [83,90,91]. A 
major drawback of this technique is the mandatory use of an N-terminal cysteine residue, as cysteines 
are seldom conveniently distributed throughout a peptide sequence. Furthermore, the polypeptide is 
generated from the C-terminus towards the N-terminus and not vice versa [85]. Another approach to 
couple two peptides includes enzyme-assisted ligation, in which enzymes are used as catalysts to 
promote peptide bond formation. This approach complements chemical ligation strategies and has 
great significance since these enzymes are naturally involved in protein modifications in vivo and are 
rated nontoxic, whereas many chemicals employed in NCL are unfavourable for food applications of 
the peptides. Nonetheless, the use of enzymes in protein crosslinking is still in its infancy and further 
research is essential to improve enzyme-assisted peptide ligation (extensively reviewed in [84]).  
Proteins often require post-translational and conformational modifications in order to render 
biological activity. As post-translational modifications cannot be provided via chemical synthesis, a 
strategy termed expressed protein ligation (EPL) or intein-mediated protein ligation (IPL) is employed. 
Following this method, semisynthetic peptides are created by fusion of recombinant peptide fragments 
to synthetic peptide fragments. Since post-translational modifications mainly occur at the termini of 
peptides, EPL is a plausible approach to obtain functional peptides [91,92]. When a disulphide bond 
pattern is essential, (re-)folding of the protein is advised and oxidative folding is performed [93–96].  
In a first attempt, oxidative folding is often employed in a direct manner, i.e., a one-step oxidative 
folding procedure, as it allows for a spontaneous fold in which the protein is energy-stable and 
assumed to acquire its native conformation. In addition, it is less expensive and time-consuming as 
compared to regioselective oxidative folding in which individual cysteine pairs are deprotected and 
oxidized sequentially to allow subsequent formation of disulphide bonds [97]. 
Functional peptides can be synthesized following SPPS and NCL methods, as was reported for 
conotoxins, snakins and defensins [94,95,97–99]. For instance, the insect defensin lucifensin, 
synthesized by Fmoc-SPPS and folded using a one-step oxidative folding technique, showed biological 
activity against Bacillus subtilis, Micrococcus luteus and Staphylococcus aureus with MIC-values of 
1.2 µM, 0.6 µM and 41 µM, resp., whereas linear unfolded lucifensin and lucifensin analogues folded 
by 1 out of 3 disulphide bridges were inactive (MIC > 100 µM) [99]. Furthermore, human β-defensin 4 
(HBD4) and HBD4 analogues, synthesized using Fmoc-SPPS and folded employing a three-step 
oxidative folding procedure, showed antimicrobial activity against Escherichia coli, Pseudomonas 
aerigunosa, S. aureus and C. albicans. However, only the completely folded peptide showed a similar 
or a 2-fold decreased activity, depending on the test organism, as commercially available HBD4 [98]. 
Although it seems that plant defensins can be produced by chemical means, multidisulphide-containing 
peptides are not always successfully produced, as multiple isoforms are generated during folding [96]. 
In addition, chemical synthesis is rather expensive due to a high cost of reagents, and peptide 
aggregation and formation of by-products renders this method often unfavourable [100,101]. These 
observations highlight the need for other systems to generate functional proteins, as will be discussed 
in the next section. 
  
Molecules 2014, 19 12292 
 
 
4.2. Heterologous Expression of Proteins 
Heterologous expression of proteins is a widely used technique and different expression systems 
have been reported to date. The main host systems used for recombinant production of AMPs include 
Escherichia coli and Pichia pastoris (reviewed in [102]).  
4.2.1. Heterologous Expression of Proteins in E. coli 
Protein expression in E. coli is relatively simple and inexpensive and the variety of available 
plasmids, fusion partners and strains makes it often the preferred method for production of  
AMPs [103,104]. However, major drawbacks have been reported using bacteria for effective AMP 
production as discussed below.  
First of all, the recombinant protein often needs to be fused to a carrier protein to neutralize its 
toxicity towards the host and to increase its solubility to avoid formation of inclusion bodies [105]. 
This fusion partner needs to be released during or after purification of the protein of interest via 
enzymatic or chemical cleavage to render functional proteins, which results in a decreased yield [102]. 
In addition, fusion proteins are not necessarily properly folded and production of these proteins can 
result in so-called “soluble inclusion bodies” [105]. Recently, it was shown that co-expression of the 
human Quiescin Sulfhydryl Oxidase (QSOX), a chaperone with thiol/disulphide oxidase activity, in 
the cytoplasm of E. coli can counter protein misfolding and increase the yield of soluble cysteine-rich 
proteins [106,107]. Although such approach improves protein production in E. coli, other obstacles remain. 
Direct secretion mechanisms are not present in E. coli strains used for recombinant protein 
production, which complicates protein purification. Protein secretion can be obtained, however, by 
destabilization of the E. coli structural components or by using leaky strains that lack certain structural 
components or mutant strains in which secretion modules derived from pathogenic E. coli or other 
species are incorporated [103,108–111].  
Finally, and most importantly, the protein of interest often requires complex folding, including the 
formation of multiple disulphide bonds and/or glycosylation. In both cases, an eukaryotic system is 
preferred [112]. In addition, Puertas and colleagues reported that the protein yield, when using E. coli 
as a host for recombinant production, is inversely proportional to the cysteine content of the protein [113]. 
This indicates the need for other expression systems when producing proteins with a high cysteine 
content, such as plant defensins. Yet, production of functional defensins in E. coli has been reported. 
For instance, using E. coli both the spruce defensin PgD5 and the Scots pine defensin PsDef1 were 
produced while displaying a high antifungal activity [114,115]. In line, functional potato snakin-1 
(SN1) and defensin-1 (PTH1) were generated using E. coli as a host [116].  
Nevertheless, peptides produced in eukaryotic systems are often more active, i.e., characterized by a 
lower MIC-value, as compared to peptides produced in prokaryotic systems. The latter is possibly due 
to structural defects or misfolding. For instance, Kant and co-workers found that the corn defensin 
PDC1 exhibited a 2-fold higher antifungal activity when produced in P. pastoris as compared to its 
production in E. coli. In addition, Fourier transform infrared spectroscopy (FTIR) revealed more  
β-sheets and less random structures when PDC1 was produced in P. pastoris [117]. Similar 
observations were made for other proteins. Both human adiponectin and alkaline phosphatase from 
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archaea were found more active when produced in P. pastoris as compared to their counterparts in  
E. coli [118,119]. Hence, these observations highlight the advantages of using P. pastoris for 
generation of functional and properly folded proteins.  
4.2.2. Heterologous Expression of Proteins in P. pastoris 
Yeasts are largely used for production of recombinant proteins due to their eukaryotic nature. 
Unlike bacteria, yeasts have the ability to implement many post-translation modifications, including 
disulphide bond formation, glycosylation and processing of signal sequences. These features make 
them attractive hosts for AMP production. Recently, the yeast P. pastoris has gained interest as a host 
for protein production for several reasons, as discussed below [120–126]. 
Firstly, P. pastoris displays a high growth rate and allows for high cell densities to be reached, 
resulting in a higher protein yield as compared to yields obtained with other eukaryotic systems 
(reviewed in [102]). P. pastoris is of particular interest for large-scale productions of recombinant 
proteins, since the growth media are cheap, universal and well defined. Furthermore, when handling 
fermenter setups in which pH, aeration, feed rate, etc. are controlled, P. pastoris can easily grow to 
ultra-high cell densities, which in turn leads to an increased protein yield [127].  
Further enhancement of the protein yield can be obtained by using multicopy transformants during 
protein production (reviewed in [128]). Multiple copies of the plasmid are often incorporated in the 
Pichia genome through crossover events and are integrated in a head-to-tail manner at the same locus. 
When using proper plasmids such as pPICZ plasmids containing a ZeocinTM resistance gene, multicopy 
transformants are selected in a straightforward manner by modulating the antibiotic concentration and 
screening for an increased antibiotic resistance [129].  
Thirdly, protein production in P. pastoris can be initiated by exogenous addition of inducing agents 
(reviewed in [126]). Initiation of protein production at any given time point is an asset, since biomass 
generation, and hence protein yield, is not affected by the potential toxicity of the protein towards the 
host [127].  
Finally, proteins produced by P. pastoris are easily exported to the culture medium using signal 
sequences, such as the S. cerevisiae α-factor sequence, which facilitates downstream processing [122,126]. 
Other signal sequences that direct the protein of interest to the secretory pathway are reviewed by 
Ahmad and colleagues [126]. A minor drawback associated with the use of the α-factor secretion 
signal is the presence of protein isoforms in which additional amino acids are incorporated at the  
N-terminus of the protein due to incomplete processing of the STE13 protease [126,130]. A non-native 
N-terminus can influence the biological activity of the protein, as was reported for the pea defensin 
Psd1 [130,131] and the shrimp AMP Ch-penaeidin [132], and is therefore inadmissible. Addition of an 
alanine or protease cleavage site at the N-terminus of the protein is recommended as it allows for 
successful cleavage of the signal sequence [126,130,133,134].  
P. pastoris has been successfully used for the production of AMPs, including hPAB-β, a variant of 
human β-defensin, and shrimp Ch-penaeidin [132,135]. Likewise, defensins from pea, tomato, 
mungbean, Mexican turnip, corn, tobacco, radish, alfalfa and barrel clover were successfully produced 
in P. pastoris [15,40,117,130,133,136–138]. These observations highlight the ease of using P. pastoris 
for production of AMPs, and more specifically, plant defensins. 
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5. Conclusions 
Plant defensins are interesting candidates for use in medicinal and biotech purposes and can be 
produced via heterologous expression in eukaryotic hosts. PDFs are generally considered non-toxic to 
plant and mammalian cells and have distinct modes of action, involving specific interactions with the 
cell surface [39]. They are therefore suggested to have great therapeutic potential, however, literature 
falls short on studies reporting the in vivo performance of PDFs in an animal model. To our 
knowledge, only RsAFP2 has been reported to show in vivo efficacy in a murine candidiasis model 
upon intravenous administration [65]. In addition, the mechanisms of action of various PDFs have not 
yet been identified or are not yet fully understood. Hence, further research is needed to demonstrate the 
therapeutic potential of PDFs and to elucidate their mechanisms of action. 
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